protiga corp

BioMARIC N.V. is a privately owned Belgian biotechnology company founded in August, 2001 predominantly focusing on prevention and control of infectious diseases. BioMARIC continuously maintains global collaboration with the third world scientific and medical community on projects that target to slow down the spread of infectious diseases. VISION Create maximum synergy between different stakeholders to make high quality healthcare products accessible at affordable prices in ALL countries of the world, in particular the growing economy countries and the countries located in resource-poor parts of the world. MISSION Develop next-generation healthcare products to control the spread of infectious diseases and make these products available through decentralized manufacturing in collaboration with local partners CERTIFICATION In 2019, BioMARIC was awarded the EN ISO 13485:2016 certification, which ensures that our products and services meet the stringent quality standards through an effective quality management system. BUSINESS PHILOSOPHY Depending on local market conditions, available know-how and targeted applications, BioMARIC cooperates with its partners to find the best model for cooperation and create maximum synergy to the benefit of all parties involved, including the local community. BioMARIC alliances can be based on several collaborative models: 1. Full Technology Transfer and supply of critical materials for local manufacturing at the partners facilities 2. Supply of selected critical detection modules developed for specific use in immunoassays 3. OEM manufacturing of the BioMARIC assay (kit) under the partners label

Biotechnology
,
Founded in unknown
11-50 employees

BioMARIC N.V. is a privately owned Belgian biotechnology company founded in August, 2001 predominantly focusing on prevention and control of infectious diseases. BioMARIC continuously maintains global collaboration with the third world scientific and medical community on projects that target to slow down the spread of infectious diseases. VISION Create maximum synergy between different stakeholders to make high quality healthcare products accessible at affordable prices in ALL countries of the world, in particular the growing economy countries and the countries located in resource-poor parts of the world. MISSION Develop next-generation healthcare products to control the spread of infectious diseases and make these products available through decentralized manufacturing in collaboration with local partners CERTIFICATION In 2019, BioMARIC was awarded the EN ISO 13485:2016 certification, which ensures that our products and services meet the stringent quality standards through an effective quality management system. BUSINESS PHILOSOPHY Depending on local market conditions, available know-how and targeted applications, BioMARIC cooperates with its partners to find the best model for cooperation and create maximum synergy to the benefit of all parties involved, including the local community. BioMARIC alliances can be based on several collaborative models: 1. Full Technology Transfer and supply of critical materials for local manufacturing at the partners facilities 2. Supply of selected critical detection modules developed for specific use in immunoassays 3. OEM manufacturing of the BioMARIC assay (kit) under the partners label

Company Information

Industry
Biotechnology
Company Type
Privately Held
Founded
unknown
Employee Range
11-50
Revenue Range
Not available

Location

Address
Klaartestraat 16 East-Flanders Zwijnaarde
City
Region
Postal Code
B-9052
Country
Canada

Web Presence

Ready to automate your outreach?

Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.

Frequently Asked Questions